|
US2735225A
(en)
|
|
1956-02-21 |
|
Table ix p petri dish tests with x-phthalimido- |
|
DE2253251A1
(de)
*
|
1972-10-30 |
1974-05-09 |
Thomae Gmbh Dr K |
Neue phthalimido-sulfonylharnstoffe
|
|
DE3474547D1
(en)
*
|
1983-12-02 |
1988-11-17 |
Shell Int Research |
Diphenyl ether herbicides
|
|
FR2659327A1
(fr)
|
1990-03-08 |
1991-09-13 |
Centre Nat Rech Scient |
Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
|
|
EP0526402B1
(en)
|
1991-07-30 |
1998-01-21 |
Novartis AG |
Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors
|
|
US5334600A
(en)
*
|
1991-07-30 |
1994-08-02 |
Ciba-Geigy Corporation |
Isoquinolyl substituted hydroxylamine derivatives
|
|
US5350761A
(en)
*
|
1991-07-30 |
1994-09-27 |
Ciba-Geigy Corporation |
Indolyl substituted hydroxylamine derivatives
|
|
TW219935B
(https=)
*
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
|
US5599811A
(en)
*
|
1995-02-21 |
1997-02-04 |
Warner-Lambert Company |
Benzothiazine dioxides as endothelin antagonists
|
|
PT891332E
(pt)
|
1996-03-29 |
2004-07-30 |
Pfizer |
Derivados de 6-fenilpiridil-2-amina
|
|
US6716836B2
(en)
|
2001-03-22 |
2004-04-06 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
|
GB0124627D0
(en)
*
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE10348022A1
(de)
|
2003-10-15 |
2005-05-25 |
Imtm Gmbh |
Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
TW200613272A
(en)
*
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
|
WO2006038594A1
(ja)
*
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
Ｎ型カルシウムチャネル阻害薬
|
|
US8110681B2
(en)
|
2006-03-17 |
2012-02-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compounds for the treatment of spinal muscular atrophy and other uses
|
|
RU2455302C2
(ru)
*
|
2006-12-27 |
2012-07-10 |
Санофи-Авентис |
ЗАМЕЩЕННЫЕ ИЗОХИНОЛИНОВЫЕ И ИЗОХИНОЛИНОНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ
|
|
JP5175866B2
(ja)
*
|
2007-02-22 |
2013-04-03 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Ｇタンパク質共役受容体を調節するための化合物および方法
|
|
US8569378B2
(en)
|
2007-07-20 |
2013-10-29 |
Toshiyuki Sakai |
p27 protein inducer
|
|
NZ592603A
(en)
*
|
2008-10-21 |
2013-02-22 |
Metabolex Inc |
Aryl gpr120 receptor agonists and uses thereof
|
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
EP2406248B1
(en)
*
|
2009-03-11 |
2013-12-25 |
Msd K.K. |
Novel isoindolin-1-one derivative
|
|
US8314120B2
(en)
*
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
|
JP5746334B2
(ja)
|
2010-06-16 |
2015-07-08 |
シマベイ セラピューティクス， インコーポレーテッド |
Ｇｐｒ１２０受容体作動薬及びその使用
|
|
TW201200505A
(en)
*
|
2010-06-17 |
2012-01-01 |
Metabolex Inc |
GPR120 receptor agonists and uses thereof
|
|
CA2841757A1
(en)
|
2011-07-15 |
2013-01-24 |
Etzer Darout |
Gpr 119 modulators
|
|
BR112014013136B1
(pt)
|
2011-11-30 |
2020-05-26 |
F. Hoffmann-La Roche Ag |
Novos derivados de dihidroisoquinolina-1-ona biciclicos
|
|
EP2906542B1
(en)
|
2012-10-11 |
2019-08-07 |
Merck Sharp & Dohme Corp. |
Substituted spiropiperidinyl compounds useful as gpr120 agonists
|
|
KR101942752B1
(ko)
*
|
2012-11-05 |
2019-01-28 |
주식회사 엘지화학 |
Ｇｐｒ120 효능제로서의 티오아릴 유도체
|
|
CA2893239A1
(en)
*
|
2012-12-03 |
2014-06-12 |
F. Hoffmann-La Roche Ag |
Substituted triazole and imidazole compounds
|
|
WO2014096941A1
(en)
*
|
2012-12-20 |
2014-06-26 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
CN105008345A
(zh)
*
|
2013-03-14 |
2015-10-28 |
詹森药业有限公司 |
可用作gpr120的激动剂的双环吡咯衍生物
|
|
WO2014159061A2
(en)
|
2013-03-14 |
2014-10-02 |
Janssen Pharmaceutica Nv |
Benzo-fused heterocyclic derivatives useful as agonists of gpr120
|
|
WO2014209034A1
(en)
|
2013-06-27 |
2014-12-31 |
Lg Life Sciences Ltd. |
Biaryl derivatives as gpr120 agonists
|
|
AR099937A1
(es)
|
2014-04-04 |
2016-08-31 |
Sanofi Sa |
Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados
|
|
DK3140296T3
(en)
|
2014-05-07 |
2018-07-23 |
Bristol Myers Squibb Co |
PYRROLIDIN GPR40 MODULATORS FOR TREATMENT OF DISEASES SUCH AS DIABETES
|
|
EP3186241B1
(en)
*
|
2014-08-29 |
2020-10-07 |
CHDI Foundation, Inc. |
Probes for imaging huntington protein
|
|
JP6486699B2
(ja)
|
2015-01-29 |
2019-03-20 |
国立大学法人金沢大学 |
脱水縮合剤
|
|
EP3365334B1
(en)
*
|
2015-10-21 |
2024-07-17 |
Otsuka Pharmaceutical Co., Ltd. |
Benzolactam compounds as protein kinase inhibitors
|
|
EP3509588B1
(en)
*
|
2016-09-12 |
2023-06-07 |
Integral Health,Inc. |
Bicyclic compounds useful as gpr120 modulators
|
|
WO2018049324A1
(en)
*
|
2016-09-12 |
2018-03-15 |
Numerate, Inc. |
Monocyclic compounds useful as gpr120 modulators
|